This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2013.
The option vested as to 25% of the underlying shares on the first anniversary of the grant date and in equal monthly installments over the following 36 months.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever NxStage Medical makes a similar move, sign up!
Other recent filings from the company include the following:
NxStage Medical's President just picked up 17,422 shares - Dec. 11, 2013
NxStage Medical's SVP and General Counsel just picked up 2,997 shares - Dec. 11, 2013
Statement of acquisition of beneficial ownership by individuals - Dec. 10, 2013
Confidential treatment order - Dec. 9, 2013